… Sustained physical exercise, advancing age, coexisting renal failure or advanced liver
disease, duration of therapy, concomitant use of insulin, drug interactions and concomitant use of …

… for someone experiencing adverse effects or drug-drug interactions from the oral medications …
A second class of insulin secretagogues is the meglitinides, which include repaglinide and …

… Drug Interactions between glimepiride and Invokana This report displays the potential drug
interactions for the following 2 drugs… dosage of the insulin secretagogue or insulin may be …

… of insulin induced by 16.7 mM glucose in isolated rat pancreatic islets [11]. Because the
mechanism by which ODN and DBI attenuate secretagoguesinduced release of insulin is … insulin …

… These agents are short-acting insulin secretagogues. Both have a similar action to SUs,
acting on the same ß-cell receptors. They act on the ATP dependent potassium channels in …

… Type 2 (non-insulin-dependent diabetes mellitus) patients, respond to insulin secretagogues
or to moderate doses of exogenous insulin [21]; new approaches that mimic insulin's effects …

… antihyperglycemic drug classes (sulfonylurea secretagogues, biguanides, α-… drug interactions
associated with sulfonylureas, including drugs that increase or decrease glucose or insulin …

… curve correlated with in vitro insulin secretion; chalcones represent potential compounds
with a powerful role as insulin secretagogues (Table 1). A strong insulin-like activity was …

… Type 2 diabetes, the most common type of diabetes, is caused by insulin resistance; … of
target organs to insulin, ii) secretagogues that increase the level of insulin secreted from the …

… Intracellular Ca2+ acts as the insulin secretagogue, as it does for the secretion of many
vesicular products. The influx of Ca2+ also activates several phospholipases, leading to the …